Natco Pharma receives FDA report for plant in Telangana
- Country:
- India
Natco Pharma receives FDA report for plant in Telangana Hyderabad, Aug 5 (PTI): Natco Pharma Limited onMonday said the US Food and Drug Administration (FDA) hasissued an establishment inspection report for its formulationsfacility in Kothur Village, Telangana
The drug-maker said the report was issued for thefacility which was inspected between May 30 and June 5 by theFDA authorities
The company had earlier said the US drug regulatorhad issued nine observations for the facility.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- plant
- Natco Pharma
- Telangana Hyderabad
- FDA
- drugmaker
- Telangana
- authorities
Advertisement
ALSO READ
Health News Roundup: US FDA approves Basilea Pharmaceutica's antibiotic, Lilly's weight-loss drug Zepbound to face supply crunch through April-end, US FDA says and more
Health News Roundup: AstraZeneca's Imfinzi shows promise in treating aggressive lung cancer; US FDA issues warning letters to retailers against underage sale of ZYN nicotine pouches and more
Health News Roundup: U.S. FDA approves expanded use of J&J's cancer cell therapy; Judge slashes Bayer $1.56 billion Roundup verdict to $611 million and more
Health News Roundup: U.S. FDA approves expanded use of J&J's cancer cell therapy; Tennessee court weighs blocking abortion ban during pregnancy complications and more
Health News Roundup: US FDA declines to approve Supernus' Parkinson's combination again; Trump says abortion laws should be decided by US states and more
Google News